Media and Press

Modernizing your supply chain is a worthy goal, and for pharmaceutical and life science companies, a big part of modernization is to outsource manufacturing and other business functions to various trading partners across the supply chain. There are many good reasons to do so. Benefits include cost savings, efficiency, specialized manufacturing capabilities and operational productivity enhancements. Companies should evaluate their core competencies and outsource where it makes the most business sense.

Hearing the unwelcome words, “You’re going to be audited,” always sends folks into a frenzy and a flurry of activity. Customs organizations all around the globe have become more and more explicit about their intent to audit every exporter and importer at some point in time.

If your company engages in global trade, you know that you have no choice but to screen every party to an export transaction. Government agencies require you to “know your customer”— as well as the banks, carriers and freight forwarders in your logistics ecosystem.

Change is good but often challenging. This is especially true when massive changes occur to regulatory data that affect international commerce. Yet a mammoth change in regulatory guidance occurs every five years that affects everyone moving goods globally.

Supply chain students worldwide will someday study the “COVID-19 years” with a magnifying glass as intensely as the Industrial Revolution.

AUSTIN, Texas and SHANGHAI – [June 29, 2021] – E2open (NYSE: ETWO), a leading network-based provider of 100% cloud-based, mission-critical, end-to-end supply chain management software, and COSCO Shipping Corporation Limited (COSCO), a Chinese multinational transportation conglomerate, today announced an extension of their partnership through 2023. COSCO will continue to utilize the INTTRA by e2open (e2open) platform for a portion of its cargo shipment bookings and instructions.

AUSTIN, Texas – June 8, 2021 – E2open (NYSE: ETWO), a leading network-based provider of 100% cloud-based, mission-critical, end-to-end supply chain management software, today announced the release of its second quarterly technology update of 2021, with added process automation and expanded artificial intelligence (AI) innovations to help clients and their partners make better, faster and more efficient decisions.

AUSTIN, Texas 05/27/2021--(BUSINESS WIRE)--E2open Parent Holdings, Inc. (NYSE: ETWO), a leading network-based provider of a 100% cloud-based, mission-critical, end-to-end supply chain management platform, today announced that it will acquire BluJay Solutions, a leading cloud-based, logistics execution platform. Based on the price of e2open’s Class A Common Stock at May 25, 2021 market close, the stock and cash transaction is valued at approximately $1.7 billion.